New Step by Step Map For Healthcare News
FTC sues main pharmacy reward administrators about insulin selling prices The company brought action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the record cost of daily life-saving insulin medicines.Elevance lowers guidance on ‘unprecedented’